These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. ATYPICAL MYCOBACTERIA IN WESTERN AUSTRALIA. CARRUTHERS KJ, EDWARDS FG. Am Rev Respir Dis; 1965 Jun; 91():887-95. PubMed ID: 14294712 [No Abstract] [Full Text] [Related]
3. EPIDEMIOLOGY OF CHRONIC BRONCHITIS AND EMPHYSEMA IN THE UNITED STATES. II. THE INTERPRETATION OF MORTALITY DATA. DEANE M. Med Thorac; 1965 Jun; 22():24-37. PubMed ID: 14309800 [No Abstract] [Full Text] [Related]
4. [Recent progress in the study of respiratory tract diseases]. Osajima S, Hara K. Naika; 1971 Jan; 27(1):81-7. PubMed ID: 4924543 [No Abstract] [Full Text] [Related]
6. [ON THE USE OF PROTEOLYTIC ENZYMES IN ASSOCIATION WITH ANTIMYCOBACTERIAL AGENTS IN THE THERAPY OF DISEASES OF THE RESPIRATORY SYSTEM]. FOSSATI C. Rass Clin Ter; 1964 Jan; 63():45-62. PubMed ID: 14127191 [No Abstract] [Full Text] [Related]
7. [The pneumophtisiologic status in 1970-1971]. Coury C, Thibault P. Rev Prat; 1972 Jan 21; 22(3):289-308. PubMed ID: 5029699 [No Abstract] [Full Text] [Related]
9. THE USE OF PROTEOLYTIC ENZYMES IN RESPIRATORY PATHOLOGY. BOURGEOIS P, BOURGEOIS D. Br J Clin Pract; 1964 Sep 21; 18():533-4. PubMed ID: 14207668 [No Abstract] [Full Text] [Related]
10. EPIDEMIOLOGY OF BRONCHITIS AND EMPHYSEMA. I. FACTORS INFLUENCING PREVALENCE AND A CRITERION FOR TESTING THEIR INTERACTION. GOLDSMITH JR. Med Thorac; 1965 Sep 21; 22():1-23. PubMed ID: 14309799 [No Abstract] [Full Text] [Related]
12. TREATMENT OF BRONCHIAL AND PULMONARY PARENCHYMAL DISORDERS. HEISEN AJ. J Med Soc N J; 1964 Mar 21; 61():104-6. PubMed ID: 14131469 [No Abstract] [Full Text] [Related]